There was a significant correlation between VEGF immunoreactivity and cumulative survival (P < 0.05), and patients with high VEGF expression had significantly higher rates of tumor recurrence within 8 months of curative surgery (P = 0.003). This evidence concerns the gene VEGFA and neoplasm.